Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

3 years ago 317

Moderna banal was climbing successful premarket trading Friday aft an expert astatine Piper Sandler upgraded the shares and said the existent terms level was an charismatic introduction point.

Edward Tenthoff upgraded Moderna (ticker: MRNA) banal to Overweight from Neutral but near the people terms unchanged astatine $445, implying a adjacent 31% upside to the shares. Piper Sandler had downgraded the shares to neutral connected Aug. 6.

“Shares...

Read Entire Article

Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

Related

How To Expand Your Business Opportunities with Guest Bloggin...

Top Pharmaceutical Stocks for Q1 2022

Cassava: An Attractive Value Proposition

AT&T Stock Has Fallen to a Multi-Decade Low. Why It Could Be...

Trending

Popular

Muḥammad ibn Mūsā al-Khwārizmī

Haiti delays constitutional referendum to September

Brazil suspends Covid-19 vaccine deal with Indian firm

Pre-market movers

CNN en Español